这项塔斯马尼亚州2040年的医疗保健长期计划(长期计划)是塔斯马尼亚州医疗保健未来的蓝图。它为提供卫生服务提供全系统的方向和策略,以实现我们的目标,以可持续,综合和平衡的卫生系统在适当的时间为我们的人口提供正确的护理。它是与塔斯马尼亚州的消费者,临床医生和政策制定者合作开发的。
•疫苗的管理日期和批处理号或品牌名称(或在空中记录了疫苗的说明)和医疗保健提供者签名和医疗保健提供者执业邮票。•未接受血清学结果。请勿使用ADT疫苗。乙型肝炎•乙型肝炎疫苗的完整历史记录(所有丙型肝炎疫苗必须记录在学生免疫记录上,包括管理日期,批量,医疗保健提供者的签名和医疗保健提供者和卫生保健提供者诊所和阳性HEP B免疫表面抗体抗体抗体抗体抗体学邮票。结果必须记录为数值值。≥10IU/L等于免疫力。Please note: ‘positive', ‘immune' or ‘detected' are not accepted OR • If a student has been vaccinated but cannot locate their Hepatitis B vaccination records, and they show ≥ 10 IU/ml Hep B immunity, verbal history of Hep B vaccinations must be recorded on the Student Immunisation Record by the health care provider along with signature and health care provider practice stamp AND Hepatitis B Vaccination Declaration that由学生完成,并由医生或授权护士免疫人员见证。该疫苗接种声明必须始终伴随塔斯马尼亚学生的免疫记录或•记录的呈阳性/检测到的乙型肝炎核心抗体的证据,表明过去的丙型肝炎感染。•如果在3次肝炎B疫苗接种后,您的HEP B免疫学血清学低于10 IU/L,请尽快与塔斯马尼亚PEP免疫团队联系以获取更多信息,因为需要进一步的HEP B疫苗接种和血清学。麻疹,腮腺炎,风疹
工作 / 研究经历 科学家:2024 年 7 月 18 日 – 至今,CSIR-中央药用和芳香植物研究所,勒克瑙,226015,印度 副教授:2023 年 11 月 1 日 – 2024 年 7 月 16 日,昌迪加尔大学生物技术大学研究所,莫哈里 助理教授:2017 年 7 月 24 日 – 2023 年 10 月 31 日,昌迪加尔大学生物技术大学研究所,莫哈里 DST 女科学家:2014 年 5 月 – 2017 年 7 月,贾瓦哈拉尔尼赫鲁 (WOS-A) 大学生命科学学院,新德里(印度)。 已完成的研究项目
表6-22:由2023-24财年批准的消费者捐款,资本赠款和补贴(卢比千万)................................................................................................................................................................... 128表6-23:债务:请愿人提交的资本化公平比率亿卢比)..129表6-24:委员会批准的债务股权比率(Rs。Crore) .................................................................................................................................................131 Table 6-25: GROSS DEPRECIATION FOR ASSETS UPTO 31.03.2020 (PART-A) SUBMITTED BY PETITIONER (Rs.Crore) .....................................................................................................................131 Table 6-26: GROSS DEPRECIATION FOR ASSETS FROM 01.04.2020 (PART-B) SUBMITTED BY PETITIONER (Rs.Crore) .....................................................................................................................132 Table 6-27: NET DEPRECIATION (PART-A + PART-B) SUBMITTED BY PETITIONER (Rs.Crore) ......132 Table 6-28: DEPRECIATION ON GFA UPTO 31.03.2020 (PART-A) APPROVED BY THE COMMISSION IN TARIFF ORDER FOR FY 2021-22 DATED JUNE 29, 2021 (Rs.Crore) ...........................................136 Table 6-29: GROSS DEPRECIATION FOR ASSETS UPTO 31.03.2020 (PART-A) APPROVED BY THE COMMISSION (Rs.Crore) ..................................................................................................................137 Table 6-30: GROSS DEPRECIATION FOR ASSETS FROM 01.04.2020 ONWARDS (PART-B) APPROVED BY THE COMMISSION (Rs.千万)...... 143表6-37:请愿人提交的股本返回Crore) ..................................................................................137 Table 6-31: NET DEPRECIATION (PART-A + PART-B) APPROVED BY THE COMMISSION (Rs.Crore) ............................................................................................................................................................138 Table 6-32: INTEREST ON LONG TERM LOANS SUBMITTED BY PETITIONER (Rs.Crore) ...............138 Table 6-33: INTEREST ON LONG TERM LOANS COMPUTED BY COMMISSION FOR FY 2022-23 PROVISONALLY (Rs.Crore)................................................................................................................140 Table 6-34: INTEREST ON LONG TERM LOAN APPROVED BY THE COMMISSION FOR FY 2023-24 (Rs.Crore) ..........................................................................................................................................141 Table 6-35: INTEREST ON WORKING CAPITAL SUBMITTED BY PETITIONER (Rs.亿卢比).................................................................................................................................................................................................................................................................................................................................................................................................................................................................Crore) .....................................144 Table 6-38: RETURN ON EQUITY PROVISIONALLY COMPUTED BY COMMISSION FOR FY 2022-23 (Rs.Crore) ..........................................................................................................................................145 Table 6-39: RETURN ON EQUITY APPROVED BY THE COMMISSION FOR FY 2023-24 (Rs.亿卢比)146表6-40:请愿人提交的非关税收入(Crore) ...................................147 Table 6-41: NON-TARIFF INCOME APPROVED BY THE COMMISSION (Rs.2022年1848年(rs。/kwh)158 < /div>Crore) .........................148 Table 6-42: INCOME FROM OTHER BUSINESS SUBMITTED BY PETITIONER (Rs.亿卢比).......................................................................................................................................................................................................................................................................................................................... 34财年提交的收入2023-24(卢比Crore) .................................................................................................................................................153 Table 6-44: INCOME FROM OTHER BUSINESS AS PER COMMISSION's ORDER DATED NOVEMBER 02, 2022 IN PETITION No.Crore) ......................................................................153 Table 6-45: INCOME FROM OTHER BUSINESS APPROVED BY THE COMMISSION (Rs.亿)..................................................................................................................................................................................................................................................................................................................了人提交的2023-24Crore) ......................155 Table 6-47: SUMMARY OF ARR SUBMITTED BY PETITIONER (Rs.Crore) .......................................156 Table 6-48: SUMMARY OF ARR APPROVED BY THE COMMISSION (RS.CRORE) ...........................157 Table 6-49: ENERGY PROJECTIONS BY PEITTIONER FOR FY 2023-24 (MUs) ..................................157 Table 6-50: TRANSMISSION TARIFF FOR FY 2023-24 AS PROJECTED BY PETITIONER (RS.
1。用于痛风关节炎条件的草药产品.............................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................使用电化学DNA传感技术的擦洗斑疹伤寒检测工具.................................Designer food to manage type-2 diabetes conditions.................................................................................... 5-6 4.生态友好的配方,以控制登革热的向量蚊子种群......................................................................................................................................... 7-8 5。Probiotic map to diagnose patients with gluten allergy & celiac disease.................................................. 9-10 6.土著2D和3D视网膜成像装置..................................................................................................................................................................................................................................................................................................................................... 11-12 7。渔业的纳米疫苗饲料...........................................................................................................................................................................................................................................................................草药配方管理蚊子种群.........................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................Rapid detection method for invasive fungal infections............................................................................. 16-17 10.Customized dental braces using ceramic moulding process..................................................................... 18-19 11.Quick and easy cervical cancer detection kit............................................................................................... 20-21 12.与骨关节炎相关的关节疼痛的干细胞疗法............................................................................................................................................................................................................................................................................................................................................................................................................... 22-23 13。Dissolvable micro-needles for efficient vaccine delivery.......................................................................... 24-25 14.An inhaler for treating long-term tuberculosis........................................................................................... 26-27 15.Jute fabric-based synthetic plaster cast for orthopaedic immobilisation................................................ 28-29 16.食品中农药的快速检测方法....................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................... 30-30 17。Bio-Desulfurization of crude oil using microorganisms.......................................................................... 31-32
• 拥有超过 6 年的计算机科学和工程经验。 • 擅长云计算、网络安全和入侵检测系统。 • 精通 NAAC 程序和有效的研究出版物。 • 具有教授核心技术科目和应用研究主题的经验。 • 具有培养引人入胜的学习环境和建立牢固关系的能力
亨斯迈先进材料是亨斯迈集团公司的国际业务单位。亨斯迈先进材料 通过在不同国家的亨斯迈集团公司关联公司经营业务,包括但不限于 Huntsman Advanced Materials LLC 在美国经营业务、 Huntsman Advanced Materials (Europe) BVBA 在欧洲经营业务,以及 Huntsman Advanced Materials (Australia) Pty Ltd, Huntsman Advanced Materials (Hong Kong) Ltd, 亨斯迈先进化工材料(广东)有限公司、 Huntsman Advanced Materials (India) Pvt Ltd 、 Huntsman Japan KK 、 Huntsman Advanced Materials (Singapore) Pte Ltd 和 Huntsman Advanced Materials (Taiwan) Corporation 在亚太区经营业务。
斯蒂芬妮·洛维奇 乔什·马雷克 莫娜·玛丽·迈尔斯·马丁内斯 尤莱卡·马丁内斯·卡斯蒂略 卡琳娜·马托斯 松波浩 伊丽莎白·马修斯 珍娜·麦克亨利 詹姆斯·麦克纳马拉 伊曼纽尔·梅德拉诺 奥黛丽·默瑟 S. 门罗 文叶灿 姜文孙 理查德·穆尼 费德里卡·莫斯蒂 多尔萨·莫特瓦利 韩牧 帕特里克·穆卡希 伊娃·瑙曼 托马斯·阮 伊丽莎白/利兹·奥戈尔曼 伊奇·奥吉罗·塞内卡 奥克森丁 塞夫吉·奥兹图尔克 凯特琳·佩斯利 安妮卡·帕特森 迈克尔·巴顿 约翰·皮尔森 黛西·佩雷斯 莎朗·波利 阿贾·普拉加纳 齐家轩 莉莉安娜·奎格利 丹尼尔·昆特罗 尼尔维卡·拉斯托吉 J. 拉塞尔·拉文内尔 纳马·赖歇尔 约瑟夫·里蒂纳 玛丽亚·鲁兹特 布莱恩·鲁伊斯·洛佩兹 劳拉·鲁普雷希特 杰弗里·拉斯 费尔南多·桑托斯·瓦伦西亚